Journal article
Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma
ND Bull, KA Irvine, RJM Franklin, KR Martin
Investigative Ophthalmology and Visual Science | ASSOC RESEARCH VISION OPHTHALMOLOGY INC | Published : 2009
DOI: 10.1167/iovs.08-3239
Abstract
PURPOSE. Glaucoma is a common neurodegenerative disease for which current therapies are often insufficient; thus, new neuroprotective strategies are an important goal. Stem cells are attracting increasing attention as mediators of neuroprotection, often conferred via the trophic support of injured neurons. The purpose of our investigation was to determine whether oligodendrocyte precursor cells (OPCs), a type of neural stem cell, can protect retinal ganglion cells (RGCs) from glaucomatous damage in vivo. METHODS. Intraocular pressure was chronically increased by trabecular laser treatment delivered unilaterally to adult rat eyes. OPCs were isolated in vitro and then transplanted intravitreal..
View full abstractGrants
Awarded by Medical Research Council
Funding Acknowledgements
Supported by Addenbrooke's Hospital (Cambridge), the Glaucoma Research Foundation, a GSK Clinician Scientist Fellowship, the Richard Norden Glaucoma Research Fund (KRM); and the UK Multiple Sclerosis Society (RJMF).